EDHB was used as a substrate of AKR1C1/C2, and KYSE 180 cells overexpressing AKR1C1/C2 were more sensitive to EDHB, which potentially provides guidance for the use of EDHB for the treatment of esophageal cancer. This evidence concerns the gene AKR1C1 and esophageal cancer.